Evaluation of efficacy in endoscopic submucosal dissection to early gastric cancer, early esophageal cancer, and/or early pharyngeal cancer by new device "Nanoshooter".
Not Applicable
- Conditions
- early gastric cancer (gastric adenoma) early esophageal cancer early pharyngeal cancer
- Registration Number
- JPRN-UMIN000008261
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Not provided
Exclusion Criteria
The exclusion criteria. 1)The patient who repeats hematemesis. 2)The patient who has a history of allergy to the use drug. 3)The patient that the withdrawal of coagulant and/or antiplatelet agent is impossible. 4)The patient with bad physical status. 5)The patient who cannot do to informed consent. 6)The patient who was considered ineligible by the investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy 1)Efficacy in nasal endoscopic submucosal dissection by oral way to early gastric cancer and/or early esophageal cancer. 2)Efficacy in nasal endoscopic submucosal dissection by nasal way to early gastric cancer, early esophageal cancer, and/or early pharyngeal cancer. Safety Treatment time, bleeding, a ratio of perforation, Visual Analog Scale
- Secondary Outcome Measures
Name Time Method